NO20034357L - Terapeutisk middel for bl¶reirriterende symptomer forbundet med benign prostatahyperplasi - Google Patents
Terapeutisk middel for bl¶reirriterende symptomer forbundet med benign prostatahyperplasiInfo
- Publication number
- NO20034357L NO20034357L NO20034357A NO20034357A NO20034357L NO 20034357 L NO20034357 L NO 20034357L NO 20034357 A NO20034357 A NO 20034357A NO 20034357 A NO20034357 A NO 20034357A NO 20034357 L NO20034357 L NO 20034357L
- Authority
- NO
- Norway
- Prior art keywords
- symptoms associated
- benign prostatic
- prostatic hyperplasia
- bladder irritation
- irritation symptoms
- Prior art date
Links
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 title 1
- 206010005052 Bladder irritation Diseases 0.000 title 1
- 208000004403 Prostatic Hyperplasia Diseases 0.000 title 1
- 208000024891 symptom Diseases 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001099799 | 2001-03-30 | ||
| PCT/JP2002/003169 WO2002078712A1 (fr) | 2001-03-30 | 2002-03-29 | Remedes de stimulation vesicale en association avec une hypertrophie de la prostate |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20034357D0 NO20034357D0 (no) | 2003-09-29 |
| NO20034357L true NO20034357L (no) | 2003-11-24 |
Family
ID=18953302
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20034357A NO20034357L (no) | 2001-03-30 | 2003-09-29 | Terapeutisk middel for bl¶reirriterende symptomer forbundet med benign prostatahyperplasi |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US7354949B2 (ko) |
| EP (1) | EP1380299A4 (ko) |
| JP (1) | JP4104986B2 (ko) |
| KR (1) | KR20040007477A (ko) |
| CN (1) | CN1230178C (ko) |
| BR (1) | BR0208416A (ko) |
| CA (1) | CA2442472A1 (ko) |
| EA (1) | EA006448B1 (ko) |
| HK (1) | HK1064616A1 (ko) |
| HU (1) | HUP0303610A3 (ko) |
| MX (1) | MXPA03008815A (ko) |
| NO (1) | NO20034357L (ko) |
| WO (1) | WO2002078712A1 (ko) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2520680A1 (en) * | 2003-03-31 | 2004-10-14 | Kyowa Hakko Kogyo Co., Ltd. | Antitussives |
| TW200501938A (en) * | 2003-06-27 | 2005-01-16 | Kyowa Hakko Kogyo Kk | A medicament for therapeutic treating overactive urinary bladder accompany with cerebrovascular disorder |
| JPWO2005007191A1 (ja) * | 2003-07-16 | 2006-08-31 | 協和醗酵工業株式会社 | 医薬組成物 |
| EP1649855A1 (en) * | 2003-07-16 | 2006-04-26 | Kyowa Hakko Kogyo Co., Ltd. | Medicinal composition |
| TW200522943A (en) * | 2003-12-11 | 2005-07-16 | Kyowa Hakko Kogyo Kk | Fine crystallites and a pharmaceutical composition comprising them |
| TW200827367A (en) | 2006-10-26 | 2008-07-01 | Kyowa Hakko Kogyo Kk | A therapeutic agent for irritable bowel syndrome |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997014672A1 (fr) | 1995-10-16 | 1997-04-24 | Kyowa Hakko Kogyo Co. Ltd. | Composes tricycliques |
| CN1260220C (zh) * | 1997-04-15 | 2006-06-21 | 协和发酵工业株式会社 | 三环类化合物 |
-
2002
- 2002-03-29 HU HU0303610A patent/HUP0303610A3/hu unknown
- 2002-03-29 KR KR10-2003-7012702A patent/KR20040007477A/ko not_active Application Discontinuation
- 2002-03-29 CN CNB028077075A patent/CN1230178C/zh not_active Expired - Fee Related
- 2002-03-29 CA CA002442472A patent/CA2442472A1/en not_active Abandoned
- 2002-03-29 EP EP02713257A patent/EP1380299A4/en not_active Withdrawn
- 2002-03-29 WO PCT/JP2002/003169 patent/WO2002078712A1/ja active Application Filing
- 2002-03-29 MX MXPA03008815A patent/MXPA03008815A/es not_active Application Discontinuation
- 2002-03-29 EA EA200301078A patent/EA006448B1/ru not_active IP Right Cessation
- 2002-03-29 JP JP2002576978A patent/JP4104986B2/ja not_active Expired - Fee Related
- 2002-03-29 BR BR0208416-3A patent/BR0208416A/pt not_active IP Right Cessation
- 2002-03-29 US US10/472,148 patent/US7354949B2/en not_active Expired - Fee Related
-
2003
- 2003-09-29 NO NO20034357A patent/NO20034357L/no not_active Application Discontinuation
-
2004
- 2004-10-07 HK HK04107683A patent/HK1064616A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| US20040110784A1 (en) | 2004-06-10 |
| US7354949B2 (en) | 2008-04-08 |
| MXPA03008815A (es) | 2004-02-17 |
| EP1380299A4 (en) | 2009-05-06 |
| HK1064616A1 (en) | 2005-02-04 |
| BR0208416A (pt) | 2004-03-02 |
| CA2442472A1 (en) | 2002-10-10 |
| EA200301078A1 (ru) | 2004-02-26 |
| JPWO2002078712A1 (ja) | 2004-07-22 |
| EP1380299A1 (en) | 2004-01-14 |
| JP4104986B2 (ja) | 2008-06-18 |
| CN1499974A (zh) | 2004-05-26 |
| WO2002078712A1 (fr) | 2002-10-10 |
| KR20040007477A (ko) | 2004-01-24 |
| EA006448B1 (ru) | 2005-12-29 |
| CN1230178C (zh) | 2005-12-07 |
| HUP0303610A3 (en) | 2005-02-28 |
| NO20034357D0 (no) | 2003-09-29 |
| HUP0303610A2 (hu) | 2004-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20034176L (no) | Pyrazolopyrimidiner som terapeutiske midler | |
| NO20034177L (no) | Pyrazolopyrimidiner som terapeutiske midler | |
| DK1212327T3 (da) | Pyrazolopyrimidiner som terapeutiske midler | |
| AR028285A1 (es) | Medicamentos intracorporeos para tratamiento fotodinamico de enfermedad | |
| NO20021329L (no) | Kinaseinhibitorer som terapeutiske midler | |
| NO20034166L (no) | Molekyl¶re konjugater for anvendelse ved behandling av cancer | |
| NO20026008D0 (no) | Fremgangsmåte for behandling av cardiovaskul¶re sykdommer | |
| PT1235558E (pt) | Agentes terapeuticos | |
| NO20024775L (no) | Hydroksyfenyl-piperidin-4-yliden-metyl-benzamid derivater til behandling avsmerte | |
| IS7444A (is) | Morfólínýl-þvagefna afleiður til notkunar við meðhöndlun á bólguvaldandi sjúkdómum | |
| NO20034560D0 (no) | Middel for topisk oftalmisk behandling av okul¶re inflammasjonssykdommer | |
| IS6137A (is) | Meðhöndlun á hugsýkistruflunum | |
| ITNA20000036A0 (it) | Nuovi approcci terapeutici per il trattamento della forfora. | |
| NO20034357L (no) | Terapeutisk middel for bl¶reirriterende symptomer forbundet med benign prostatahyperplasi | |
| HK1085373A1 (en) | Compound and use in the manufacture of a medicament for the treatment of benign prostatic hyperplasia and associated symptoms | |
| CY1105814T1 (el) | Δαριφενακινη για χρηση στη θεραπεια της επειξης προς ουρηση λογω υπepλειτουργικης ουροδοχου κυστης | |
| EE200200605A (et) | Asendatud akrüloüüldistamütsiini derivaadi kasutamine ravimi valmistamiseks, mis on ette nähtud glutatiooni kõrge tasemega seotud kasvajate raviks | |
| NO20034358L (no) | Terapeutisk middel for bl¶rehypersensitivitet | |
| FR2805983B3 (fr) | Douche | |
| EP1372639A4 (en) | TREATMENT AGENT FOR BLADDER IRRITATION SYMPTOMS ACCOMPANIED WITH BENIGN PROSTATIC HYPERPLASIA | |
| NO20032206L (no) | Kombinasjonsterapi for östrogen-avhengige forstyrrelser | |
| NO20025760D0 (no) | S-metyl-dihydro-ziprasidon for behandling av psykiatriske og okkul¶re forstyrrelser | |
| NO20034356L (no) | Terapeutisk middel for overaktiv bl¶re | |
| PT1305314E (pt) | Agente terapeutico cristalino | |
| DK1305314T3 (da) | Krystallinsk terapeutisk middel |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |